FDA Advises Patients to Switch to HFA-Propelled Albuterol Inhalers Now
The U.S. Food and Drug Administration today issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane (HFA)-propelled albuterol inhalers because chlorofluorocarbon (CFC)-propelled inhalers will not be available in the United States after Dec. 31, 2008...
Friday, May 30, 2008
FDA Advises Patients to Switch to HFA-Propelled Albuterol Inhalers Now
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment